Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
567.00 K USD
151.00 K USD
31.06 M
About Septerna, Inc.
Sector
CEO
Jeffrey T. Finer
Headquarters
South San Francisco
Website
Founded
2019
FIGI
BBG014WY1V28
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SEPN is 25.90 USD — it has decreased by −4.39% in the past 24 hours. Watch Septerna, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Septerna, Inc. stocks are traded under the ticker SEPN.
SEPN stock has risen by 21.37% compared to the previous week, the month change is a 19.91% rise, over the last year Septerna, Inc. has showed a 10.21% increase.
We've gathered analysts' opinions on Septerna, Inc. future price: according to them, SEPN price has a max estimate of 50.00 USD and a min estimate of 38.00 USD. Watch SEPN chart and read a more detailed Septerna, Inc. stock forecast: see what analysts think of Septerna, Inc. and suggest that you do with its stocks.
SEPN reached its all-time high on Dec 4, 2024 with the price of 27.47 USD, and its all-time low was 18.62 USD and was reached on Oct 30, 2024. View more price dynamics on SEPN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SEPN stock is 11.17% volatile and has beta coefficient of 3.10. Track Septerna, Inc. stock price on the chart and check out the list of the most volatile stocks — is Septerna, Inc. there?
Yes, you can track Septerna, Inc. financials in yearly and quarterly reports right on TradingView.
Septerna, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SEPN earnings for the last quarter are −8.40 USD per share, whereas the estimation was −5.88 USD resulting in a −42.94% surprise. The estimated earnings for the next quarter are −0.69 USD per share. See more details about Septerna, Inc. earnings.
Septerna, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 150.00 K USD. In the next quarter, revenue is expected to reach 150.00 K USD.
SEPN net income for the last quarter is −20.52 M USD, while the quarter before that showed −10.95 M USD of net income which accounts for −87.51% change. Track more Septerna, Inc. financial stats to get the full picture.
No, SEPN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SEPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Septerna, Inc. stock right from TradingView charts — choose your broker and connect to your account.